Cargando…
Efficacy of Adjunctive Subconjunctival Bevacizumab on the Outcomes of Primary Trabeculectomy With Mitomycin C: A Prospective Randomized Placebo-controlled Trial
PURPOSE: To evaluate the efficacy of subconjunctival bevacizumab (ScB) as adjuvant therapy to primary trabeculectomy with mitomycin C (MMC) in primary open-angle glaucoma. MATERIALS AND METHODS: Forty-six eyes of primary open-angle glaucoma patients were randomized to receive ScB (1.25 mg/0.05 mL) i...
Autores principales: | Kiddee, Weerawat, Orapiriyakul, Lachaya, Kittigoonpaisan, Kaneungnit, Tantisarasart, Thawat, Wangsupadilok, Boonchai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Raven Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614532/ https://www.ncbi.nlm.nih.gov/pubmed/25393038 http://dx.doi.org/10.1097/IJG.0000000000000194 |
Ejemplares similares
-
Subconjunctival bevacizumab to augment trabeculectomy with mitomycin C in the management of failed glaucoma surgery
por: Saeed, Ahmed M, et al.
Publicado: (2014) -
Evaluation of topical bevacizumab as an adjunct to mitomycin C augmented trabeculectomy
por: Zarei, Reza, et al.
Publicado: (2016) -
Subconjunctival Bevacizumab as an Adjunct to Trabeculectomy in Eyes with Refractory Glaucoma: A Case Series
por: Choi, Jin Young, et al.
Publicado: (2010) -
Postoperative subconjunctival bevacizumab injection as an adjunct to 5-fluorouracil in the management of scarring after trabeculectomy
por: Freiberg, Florentina Joyce, et al.
Publicado: (2013) -
Low-dose subconjunctival bevacizumab to augment trabeculectomy for glaucoma
por: Sedghipour, Mohammad-Reza, et al.
Publicado: (2011)